Learning objectives: To learn about the preclinical stage of Alzheimer’s disease and risk of cognitive decline.

To evaluate imaging and biomarker detection of early Alzheimer’s disease.

Session date: 
Tuesday, November 10, 2020 - 12:00pm to 1:00pm
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Reisa A. Sperling, MD